Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

8,376 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
[Knocking down rat Mecp2 expression by RNAi].
Zhang YZ, Wang HS, Pan H, Li MR, Bao XH, Jin J, Wu XR. Zhang YZ, et al. Among authors: jin j. Beijing Da Xue Xue Bao Yi Xue Ban. 2006 Oct 18;38(5):529-32. Beijing Da Xue Xue Bao Yi Xue Ban. 2006. PMID: 17068630 Chinese.
Copanlisib plus rituximab versus placebo plus rituximab in patients with relapsed indolent non-Hodgkin lymphoma (CHRONOS-3): a double-blind, randomised, placebo-controlled, phase 3 trial.
Matasar MJ, Capra M, Özcan M, Lv F, Li W, Yañez E, Sapunarova K, Lin T, Jin J, Jurczak W, Hamed A, Wang MC, Baker R, Bondarenko I, Zhang Q, Feng J, Geissler K, Lazaroiu M, Saydam G, Szomor Á, Bouabdallah K, Galiulin R, Uchida T, Soler LM, Cao A, Hiemeyer F, Mehra A, Childs BH, Shi Y, Zinzani PL. Matasar MJ, et al. Among authors: jin j. Lancet Oncol. 2021 Apr 9:S1470-2045(21)00145-5. doi: 10.1016/S1470-2045(21)00145-5. Online ahead of print. Lancet Oncol. 2021. PMID: 33848462
8,376 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page